 | This article's tone or style may not reflect the encyclopedic tone used on Wikipedia. (December 2020) |
The 340B Drug Pricing Program is a US federal government program created in 1992 that requires drug manufacturers to provide outpatient drugs to eligible health care organizations and covered entities at significantly reduced prices. The intent of the program is to allow covered entities to "stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services."[1][2][3] Maintaining services and lowering medication costs for patients is consistent with the purpose of the program, which is named for the section authorizing it in the Public Health Service Act (PHSA)[4][5][6] It was enacted by Congress as part of a larger bill signed into law by President George H. W. Bush.
- ^ "340B Drug Pricing Program - Official web site of the U.S. Health Resources & Services Administration". Hrsa.gov. Retrieved 17 July 2018.
- ^ Veterans Health Care Act of 1992, Pub. L. No. 102-585 § 602, 106 Stat. 4943, 4967-4971 (1992).
- ^ GAO, Drug Pricing: Manufacturer Discounts in the 340B Program Offer Benefits, but Federal Oversight Needs Improvement, GAO (Washington, D.C.: Sep. 2011) at 1 [hereafter referred to as GAO 340B Report].
- ^ GAO 340B Report p. 1:"Thirteen of the 29 covered entities we interviewed reported that they generated 340B program revenue that exceeded drug-related costs, which includes the costs of purchasing and dispensing drugs."
- ^ "340B Drug Pricing Program". Hrsa.gov.
- ^ [1][permanent dead link]